The U.S. Food and Drug Administration discovered breast implant-associated anaplastic large cell lymphoma, which is related to breast implants in 2011. As more and more cases appeared, many countries started to discuss the importance of breast implant registry. According to Taiwan's current regulations, medical records can only be kept for seven years, so Taiwan needs a long-term registration system to monitor and track the safety of breast implants. Therefore, in 2020, Taiwan Food and Drug Administration started a project that expects to establish the breast implant registry in Taiwan. The aim of this study is to discuss how to establish and develop a breast implant registration system in Taiwan and how it can be planned in the future.
The research team collected and compiled the data of the operating breast implant registry in countries around the world, and interviewed the person in charge of the breast implants registry in the Netherlands and Australia. In addition, the research team confirmed that the system process is well-designed by interviewing experts in related fields and holding expert meetings. Based on the operating models of these countries and the opinions of experts in related fields in Taiwan, the research team developed the Taiwan Breast Implant Registry (TBIR), a local operating model of Taiwan, and designed the content and operation process of the system.
Taiwan has established a pilot system of Taiwan Breast Implant Registry and will soon be promoted. However, there are still many challenges to overcome at present, such as how to effectively promote the system, how to improve the review mechanism, etc. These obstacles also need to be overcome in the future. If we can overcome these obstacles, the system is believed to be helpful for monitoring the quality of breast implants. In addition, when breast implants encounter safety problems, the system can also be used to track quickly and inform patients.

Download